Paratek Pharmaceuticals
Latest round
- Series D
Last raised
- Apr 2002
Total raised
- $30M
Investors
- 10
About Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc.Paratek Pharmaceuticals, Inc. specializes in developing antibiotic solutions, particularly for resistant bacterial strains. The company was founded in 1996 and is headquartered in Boston, Massachusetts. Paratek was formed after a merger with Transcept Pharmaceuticals, Inc. in 2014, which has informed its strategic direction.Paratek Pharmaceuticals specializes in the development and commercialization of innovative therapies focused on addressing antimicrobial resistance (AMR). The company's core product, NUZYRA®, is an antibiotic that targets a range of bacterial infections, including those caused by resistant strains. This product is designed for patients suffering from conditions such as community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections, providing an essential solution in the fight against superbugs.S. and select international markets, serving hospitals, healthcare providers, and specialty pharmacies that cater to patients requiring advanced antibiotic therapies.27 mn for the year 2022. The company’s structure relies on direct sales to hospitals and clinics, where products are crucial for treating serious bacterial infections. Paratek's transactions include agreements with hospitals and healthcare networks ensuring timely access for patients, aligned with the critical nature of its therapeutic applications.. The company is targeting expansion into new markets and geographic regions, focusing on international healthcare systems that require advanced antibiotic solutions., a portfolio company of Gurnet Point Capital.
Who invested in Paratek Pharmaceuticals
10 investors across 1 round
See all investors in Paratek Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Apr 26, 2002
Amount
$30M
Investors
Questions about Paratek Pharmaceuticals
Who invested in Paratek Pharmaceuticals?
Paratek Pharmaceuticals has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Paratek Pharmaceuticals raised?
Paratek Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Paratek Pharmaceuticals last raise money?
Paratek Pharmaceuticals's most recent round on record is a Series D, in Apr 2002.
What does Paratek Pharmaceuticals do?
Paratek Pharmaceuticals is a pharmaceuticals company.
Where is Paratek Pharmaceuticals headquartered?
Paratek Pharmaceuticals is headquartered in King of Prussia, US.
Which VCs invest in companies like Paratek Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Paratek Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Paratek Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.